Found: 123
Select item for more details and to access through your institution.
Efficacy of Zinc Acetate Treatment for Patients with Decompensated Liver Cirrhosis Complicated by Hypozincemia.
- Published in:
- Biological Trace Element Research, 2022, v. 200, n. 2, p. 497, doi. 10.1007/s12011-021-02675-5
- By:
- Publication type:
- Article
Comparative analysis of the therapeutic outcomes of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma patients aged 80 years and older: Multicenter study.
- Published in:
- Hepatology Research, 2024, v. 54, n. 4, p. 382, doi. 10.1111/hepr.13991
- By:
- Publication type:
- Article
Geriatric nutritional risk index as an easy‐to‐use assessment tool for nutritional status in hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
- Published in:
- Hepatology Research, 2023, v. 53, n. 10, p. 1031, doi. 10.1111/hepr.13934
- By:
- Publication type:
- Article
Association of proton pump inhibitor and antibiotic use with the clinical outcomes of hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: A multicenter analysis.
- Published in:
- Hepatology Research, 2023, v. 53, n. 8, p. 737, doi. 10.1111/hepr.13905
- By:
- Publication type:
- Article
Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child‐Pugh class A or B liver function in real‐world clinical practice.
- Published in:
- Hepatology Research, 2022, v. 52, n. 9, p. 773, doi. 10.1111/hepr.13797
- By:
- Publication type:
- Article
Association of early bevacizumab interruption with efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: A landmark analysis.
- Published in:
- Hepatology Research, 2022, v. 52, n. 5, p. 462, doi. 10.1111/hepr.13748
- By:
- Publication type:
- Article
Early experience of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma BCLC‐B stage patients classified as beyond up to seven criteria – Multicenter analysis.
- Published in:
- Hepatology Research, 2022, v. 52, n. 3, p. 308, doi. 10.1111/hepr.13734
- By:
- Publication type:
- Article
Carbon ion radiotherapy for patients with hepatocellular carcinoma in the caudate lobe carbon ion radiotherapy for hepatocellular carcinoma in caudate lobe.
- Published in:
- Hepatology Research, 2021, v. 51, n. 3, p. 303, doi. 10.1111/hepr.13606
- By:
- Publication type:
- Article
Real‐world efficacy and safety of 12‐week sofosbuvir/velpatasvir treatment for patients with decompensated liver cirrhosis caused by hepatitis C virus infection.
- Published in:
- Hepatology Research, 2021, v. 51, n. 1, p. 51, doi. 10.1111/hepr.13576
- By:
- Publication type:
- Article
Attempt to Establish Prognostic Predictive System for Hepatocellular Carcinoma Using Artificial Intelligence for Assistance with Selection of Treatment Modality.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 565, doi. 10.1159/000530078
- By:
- Publication type:
- Article
Relationship of Atezolizumab plus Bevacizumab Treatment with Muscle Volume Loss in Unresectable Hepatocellular Carcinoma Patients: Multicenter Analysis.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 209, doi. 10.1159/000527402
- By:
- Publication type:
- Article
Efficacy and Safety of 4 Fractions of Carbon-Ion Radiation Therapy for Hepatocellular Carcinoma: A Prospective Study.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 1, p. 61, doi. 10.1159/000520277
- By:
- Publication type:
- Article
A Prospective Randomized Controlled Trial of AJG522 versus Standard PEG + E as Bowel Preparation for Colonoscopy.
- Published in:
- BioMed Research International, 2015, v. 2015, p. 1, doi. 10.1155/2015/521756
- By:
- Publication type:
- Article
Evaluation of twice-daily administration of interferon-β for chronic hepatitis C.
- Published in:
- Journal of Viral Hepatitis, 1999, v. 6, n. 4, p. 315, doi. 10.1046/j.1365-2893.1999.00168.x
- By:
- Publication type:
- Article
Constitutive active/androstane receptor promotes hepatocarcinogenesis in a mouse model of non-alcoholic steatohepatitis.
- Published in:
- Carcinogenesis, 2011, v. 32, n. 4, p. 576, doi. 10.1093/carcin/bgq277
- By:
- Publication type:
- Article
Successful Treatment of Metastatic Gallbladder Carcinoma with a High Tumor Mutational Burden Using Pembrolizumab.
- Published in:
- Internal Medicine, 2023, v. 62, n. 21, p. 3151, doi. 10.2169/internalmedicine.1610-23
- By:
- Publication type:
- Article
Chronic Infection with Hepatitis C Virus Subtype 1g in a Japanese Patient Successfully Treated with Glecaprevir/Pibrentasvir.
- Published in:
- Internal Medicine, 2022, v. 61, n. 10, p. 1537, doi. 10.2169/internalmedicine.8673-21
- By:
- Publication type:
- Article
An Autopsy Case of Multicentric Castleman Disease Presenting with Severe Jaundice.
- Published in:
- Internal Medicine, 2021, v. 60, n. 22, p. 3615, doi. 10.2169/internalmedicine.6835-20
- By:
- Publication type:
- Article
Follow-up after Direct-acting Antiviral Treatment for Chronic Hepatitis C Virus Infection: Most Patients Are Followed Appropriately.
- Published in:
- Internal Medicine, 2021, v. 60, n. 19, p. 3061, doi. 10.2169/internalmedicine.6591-20
- By:
- Publication type:
- Article
Comparison of prognostic impact of atezolizumab plus bevacizumab versus lenvatinib in patients with intermediate‐stage hepatocellular carcinoma.
- Published in:
- Liver International, 2024, v. 44, n. 1, p. 113, doi. 10.1111/liv.15753
- By:
- Publication type:
- Article
Favorable outcome of retreatment by direct‐acting antivirals for hepatitis C patients with daclatasvir plus asunaprevir combination therapy failure.
- Published in:
- Hepatology Research, 2020, v. 50, n. 3, p. 303, doi. 10.1111/hepr.13462
- By:
- Publication type:
- Article
Analyses of objective response rate, progression‐free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective study.
- Published in:
- Hepatology Research, 2020, v. 50, n. 3, p. 382, doi. 10.1111/hepr.13460
- By:
- Publication type:
- Article
Elevated serum uric acid level was a notable adverse event during combination therapy with sofosbuvir and ribavirin.
- Published in:
- Hepatology Research, 2018, v. 48, n. 3, p. E347, doi. 10.1111/hepr.12971
- By:
- Publication type:
- Article
Factors predicting overall response and overall survival in hepatocellular carcinoma patients undergoing balloon‐occluded transcatheter arterial chemoembolization: A retrospective cohort study.
- Published in:
- Hepatology Research, 2018, v. 48, n. 2, p. 165, doi. 10.1111/hepr.12912
- By:
- Publication type:
- Article
Spontaneous remission of hepatitis B virus reactivation during direct-acting antiviral agent-based therapy for chronic hepatitis C.
- Published in:
- Hepatology Research, 2017, v. 47, n. 12, p. 1346, doi. 10.1111/hepr.12905
- By:
- Publication type:
- Article
Clinical and virological features of acute hepatitis E in Gunma prefecture, Japan between 2004 and 2015.
- Published in:
- Hepatology Research, 2017, v. 47, n. 5, p. 435, doi. 10.1111/hepr.12765
- By:
- Publication type:
- Article
Expression of amino acid transporters ( LAT1, ASCT2 and xCT) as clinical significance in hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2015, v. 45, n. 9, p. 1014, doi. 10.1111/hepr.12431
- By:
- Publication type:
- Article
Safety and efficacy of balloon-occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2015, v. 45, n. 6, p. 663, doi. 10.1111/hepr.12403
- By:
- Publication type:
- Article
Response-guided peginterferon-alpha-2b plus ribavirin therapy for chronic hepatitis C patients with genotype 2 and high viral loads.
- Published in:
- Hepatology Research, 2012, v. 42, n. 9, p. 854, doi. 10.1111/j.1872-034X.2012.00997.x
- By:
- Publication type:
- Article
Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Clinical Characteristics, Prognosis, and Patient Survival Analysis.
- Published in:
- Digestive Diseases & Sciences, 2007, v. 52, n. 11, p. 3290, doi. 10.1007/s10620-007-9808-2
- By:
- Publication type:
- Article
A Large Flat Adenoma Located on the Pylorus Ring Successfully Treated by Endoscopic Submucosal Dissection.
- Published in:
- Digestive Diseases & Sciences, 2007, v. 52, n. 7, p. 1738, doi. 10.1007/s10620-006-9567-5
- By:
- Publication type:
- Article
Hepatocellular Carcinoma in Young Adults: The Clinical Characteristics, Prognosis, and Findings of a Patient Survival Analysis.
- Published in:
- Digestive Diseases & Sciences, 2007, v. 52, n. 4, p. 1103, doi. 10.1007/s10620-006-9578-2
- By:
- Publication type:
- Article
Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma: Clinical Results Show Importance of Hepatic Reserve Function.
- Published in:
- Oncology, 2023, v. 101, n. 10, p. 624, doi. 10.1159/000531316
- By:
- Publication type:
- Article
Comparison between Atezolizumab Plus Bevacizumab and Lenvatinib for Hepatocellular Carcinoma in Patients with Child-Pugh Class B in Real-World Clinical Settings.
- Published in:
- Oncology, 2023, v. 101, n. 9, p. 542, doi. 10.1159/000530028
- By:
- Publication type:
- Article
Nutritional Status Is Associated with Prognosis in Patients with Advanced Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.
- Published in:
- Oncology, 2023, v. 101, n. 4, p. 270, doi. 10.1159/000527676
- By:
- Publication type:
- Article
Increased Spleen Volume in Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab in Comparison to Lenvatinib: A Retrospective Analysis.
- Published in:
- Oncology, 2023, v. 101, n. 3, p. 193, doi. 10.1159/000528081
- By:
- Publication type:
- Article
Clinical Predictor of Urinary Protein as Adverse Event Associated with Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma.
- Published in:
- Oncology, 2022, v. 100, n. 12, p. 645, doi. 10.1159/000526521
- By:
- Publication type:
- Article
Efficacy and Safety of the Combination of Nano-Liposomal Irinotecan and 5-Fluorouracil/L-Leucovorin in Unresectable Advanced Pancreatic Cancer: A Real-World Study.
- Published in:
- Oncology, 2022, v. 100, n. 8, p. 449, doi. 10.1159/000525742
- By:
- Publication type:
- Article
Simple Scoring System for Predicting TACE Unsuitable among Intermediate-Stage Hepatocellular Carcinoma Patients in the Multiple Systemic Treatment Era.
- Published in:
- Oncology, 2022, v. 100, n. 2, p. 65, doi. 10.1159/000520292
- By:
- Publication type:
- Article
Lenvatinib for Hepatocellular Carcinoma Patients with Nonviral Infection Who Were Unlikely to Respond to Immunotherapy: A Retrospective, Comparative Study.
- Published in:
- Oncology, 2021, v. 99, n. 10, p. 641, doi. 10.1159/000517494
- By:
- Publication type:
- Article
The Role of the Albumin-Bilirubin Score for Predicting the Outcomes in Japanese Patients with Advanced Hepatocellular Carcinoma Treated with Ramucirumab: A Real-World Study.
- Published in:
- Oncology, 2021, v. 99, n. 4, p. 203, doi. 10.1159/000511734
- By:
- Publication type:
- Article
Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma.
- Published in:
- Cancer Reports, 2024, v. 7, n. 4, p. 1, doi. 10.1002/cnr2.2042
- By:
- Publication type:
- Article
Initial clinical experience with durvalumab plus tremelimumab in patients with unresectable hepatocellular carcinoma in real‑world practice.
- Published in:
- Oncology Letters, 2024, v. 28, n. 2, p. N.PAG, doi. 10.3892/ol.2024.14530
- By:
- Publication type:
- Article
Outcomes of patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab in real‐world clinical practice who met or did not meet the inclusion criteria for the phase 3 IMbrave150 trial.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 2, p. 233, doi. 10.1111/apt.18037
- By:
- Publication type:
- Article
Machine learning improves the prediction of significant fibrosis in Asian patients with metabolic dysfunction‐associated steatotic liver disease – The Gut and Obesity in Asia (GO‐ASIA) Study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 6, p. 774, doi. 10.1111/apt.17891
- By:
- Publication type:
- Article
Improved survival of viral hepatocellular carcinoma but not non‐viral hepatocellular carcinoma from 2000 to 2020: A multi‐centre cohort study of 6007 patients from high‐volume academic centres in Japan.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 4, p. 694, doi. 10.1111/apt.17088
- By:
- Publication type:
- Article
A comparison of carbon ion radiotherapy and transarterial chemoembolization treatment outcomes for single hepatocellular carcinoma: a propensity score matching study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Prospective Randomized Controlled Study of Long-Term Combination Therapy Using Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis and Dyslipidemia.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2015, v. 110, n. 3, p. 423, doi. 10.1038/ajg.2015.20
- By:
- Publication type:
- Article
Pancreatic and gastric metastases of leiomyosarcoma arising in the left leg.
- Published in:
- International Journal of Clinical Oncology, 2005, v. 10, n. 5, p. 342, doi. 10.1007/s10147-005-0487-8
- By:
- Publication type:
- Article
Characteristics of cabozantinib treatment in advanced hepatocellular carcinoma.
- Published in:
- Liver Cancer International, 2023, v. 4, n. 3, p. 101, doi. 10.1002/lci2.74
- By:
- Publication type:
- Article